Search
for
Sort by
Research 61–90 of 522
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- The JAK/STAT signaling pathway: from bench to clinic
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Role of janus kinase inhibitors in the treatment of alopecia areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports